Letter: Transfer-factor therapy in multiple sclerosis.
D000914:Antibodies, Viral; D003587:Cytomegalovirus / Q000276:immunology; D000939:Epitopes; D006649:Histocompatibility Antigens / Q000032:analysis; D006801:Humans; D007104:Immune Adherence Reaction; D007111:Immunity, Cellular; D007116:Immunization, Passive; D007153:Immunologic Deficiency Syndromes / Q000150:complications; D007962:Leukocytes / Q000276:immunology; D008213:Lymphocyte Activation; D008263:Macrophage Migration-Inhibitory Factors; D009103:Multiple Sclerosis / Q000097:blood / Q000150:complications / Q000276:immunology / Q000382:microbiology / Q000628:therapy*; D010252:Paramyxoviridae / Q000276:immunology
D000914:Antibodies, Viral; D000939:Epitopes; D006649:Histocompatibility Antigens; D008263:Macrophage Migration-Inhibitory Factors